Archives of Gynecology and Obstetrics

, Volume 298, Issue 1, pp 27–34 | Cite as

Placenta previa and placental abruption after assisted reproductive technology in patients with endometriosis: a systematic review and meta-analysis

  • Maria Luisa Gasparri
  • Konstantinos Nirgianakis
  • Katayoun Taghavi
  • Andrea Papadia
  • Michael D Mueller



Recent evidence suggests that assisted reproductive technology (ART) increases the risk of adverse pregnancy outcomes, including placental disorders. Similarly, endometriosis resulted detrimental on placenta previa. However, up to 50% of women with endometriosis suffer from infertility, thus requiring ART. The aim of our metanalysis is to compare women with and without endometriosis undergoing ART in terms of placenta disorders events, to establish if ART itself or endometriosis, as an indication to ART, increases the risk of placenta previa.


Literature searches were conducted in January 2018 using electronic databases (PubMed, Medline, Scopus, Embase, Science Direct, and the Cochrane Library Scopus). Series comparing pregnancy outcome after ART in women with and without endometriosis were screened and data on placenta previa and placental abruption were extracted.


Five retrospective case–control studies met the inclusion criteria. The meta-analysis revealed that endometriosis is associated with an increased risk of placenta previa in pregnancies achieved through ART (OR 2.96 (95% CI 1.25–7.03); p = 0.01, I2 =69%, random-effect model). No differences in placental abruption incidence were found (OR 0.44 (95% CI 0.10–1.87); p = 0.26, I2 = 0%, fixed-effect model).


Patients with endometriosis undergoing ART may have additional risk of placenta previa. Despite the inability to determine if endometriosis alone or endometriosis plus ART increase the risk, physicians should be aware of the potential additional risk that endometriosis patients undergoing ART harbor.


Placental abruption Placenta previa Assisted reproduction Endometriosis Adverse pregnancy outcome 


Author contributions

MLG was responsible for the conceptualization, literature search, data extraction, and statistical analysis. The paper was equally drafted by MLG, KN, and KT. MM and AP performed the final revision.

Compliance with ethical standards

Conflict of interest

The authors declare to have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.


  1. 1.
    Giudice LC, Kao LC (2004) Endometriosis. Lancet 364:1789–1799CrossRefPubMedGoogle Scholar
  2. 2.
    Eskenazi B, Warner ML (1997) Epidemiology of endometriosis. Obstet Gynecol Clin North Am 24:235–258CrossRefPubMedGoogle Scholar
  3. 3.
    Qin JB, Sheng XQ, Wang H et al (2017) Worldwide prevalence of adverse pregnancy outcomes associated with in vitro fertilization/intracytoplasmic sperm injection among multiple births: a systematic review and meta-analysis based on cohort studies. Arch Gynecol Obstet 295:577–597CrossRefPubMedGoogle Scholar
  4. 4.
    Karami M, Jenabi E, Fereidooni B et al (2017) The association of placenta previa and assisted reproductive techniques: a meta-analysis. J Matern Fetal Neonatal Med 6:1–8Google Scholar
  5. 5.
    McArthur JW, Ulfelder H (1965) The effect of pregnancy upon endometriosis. Obstet Gynecol Surv 20:709–733CrossRefPubMedGoogle Scholar
  6. 6.
    Aris A (2014) A 12-year cohort study on adverse pregnancy outcomes in Eastern Townships of Canada: impact of endometriosis. Gynecol Endocrinol 30:34–37CrossRefPubMedGoogle Scholar
  7. 7.
    Benaglia L, Candotti G, Papaleo E et al (2016) Pregnancy outcome in women with endometriosis achieving pregnancy with IVF. Hum Reprod 31:2730–2736CrossRefPubMedGoogle Scholar
  8. 8.
    Brosens IA, De Sutter P, Hamerlynck T et al (2007) Endometriosis is associated with a decreased risk of pre-eclampsia. Hum Reprod 22:1725–1729CrossRefPubMedGoogle Scholar
  9. 9.
    Conti N, Cevenini G, Vannuccini S et al (2015) Women with endometriosis at first pregnancy have an increased risk of adverse obstetric outcome. J Matern Fetal Neonatal Med 28:1795–1798CrossRefPubMedGoogle Scholar
  10. 10.
    Exacoustos C, Lauriola I, Lazzeri L et al (2016) Complications during pregnancy and delivery in women with untreated rectovaginal deep infiltrating endometriosis. Fertil Steril 106:1129CrossRefPubMedGoogle Scholar
  11. 11.
    Fernando S, Breheny S, Jaques AM et al (2009) Preterm birth, ovarian endometriomata, and assisted reproduction technologies. Fertil Steril 91:325–330CrossRefPubMedGoogle Scholar
  12. 12.
    Glavind MT, Forman A, Arendt LH et al (2017) Endometriosis and pregnancy complications: a Danish cohort study. Fertil Steril 107:160–166CrossRefPubMedGoogle Scholar
  13. 13.
    Hadfield RM, Lain SJ, Raynes-Greenow CH et al (2009) Is there an association between endometriosis and the risk of pre-eclampsia? A population based study. Hum Reprod 24:2348–2352CrossRefPubMedGoogle Scholar
  14. 14.
    Jacques M, Freour T, Barriere P et al (2016) Adverse pregnancy and neo-natal outcomes after assisted reproductive treatment in patients with pelvic endometriosis: a case–control study. Reprod Biomed Online 32:626–634CrossRefPubMedGoogle Scholar
  15. 15.
    Kortelahti M, Anttila MA, Hippelainen MI et al (2003) Obstetric outcome in women with endometriosis–a matched case–control study. Gynecol Obstet Investig 56:207–212CrossRefGoogle Scholar
  16. 16.
    Kuivasaari-Pirinen P, Raatikainen K, Hippelainen M et al (2012) Adverse outcomes of IVF/ICSI pregnancies vary depending on aetiology of infertility. ISRN Obstet Gynecol 2012:451915CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Lin H, Leng JH, Liu JT et al (2015) Obstetric outcomes in Chinese women with endometriosis: a retrospective cohort study. Chin Med J (Engl) 128:455–458CrossRefGoogle Scholar
  18. 18.
    Mannini L, Sorbi F, Noci I, Ghizzoni V et al (2017) New adverse obstetrics outcomes associated with endometriosis: a retrospective cohort study. Arch Gynecol Obstet 295:141–151CrossRefPubMedGoogle Scholar
  19. 19.
    Mekaru K, Masamoto H, Sugiyama H et al (2014) Endometriosis and pregnancy outcome: are pregnancies complicated by endometriosis a high-risk group? Eur J Obstet Gynecol Reprod Biol 172:36–39CrossRefPubMedGoogle Scholar
  20. 20.
    Saraswat L, Ayansina DT, Cooper KG et al (2017) Pregnancy outcomes in women with endometriosis: a national record linkage study. BJOG 124:444–452CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Stephansson O, Kieler H, Granath F et al (2009) Endometriosis, assisted reproduction technology, and risk of adverse pregnancy outcome. Hum Reprod 24:2341–2347CrossRefPubMedGoogle Scholar
  22. 22.
    Stern JE, Luke B, Tobias M et al (2015) Adverse pregnancy and birth outcomes associated with underlying diagnosis with and without assisted reproductive technology treatment. Fertil Steril 103:1438–1445CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Takemura Y, Osuga Y, Fujimoto A et al (2013) Increased risk of placenta previa is associated with endometriosis and tubal factor infertility in assisted reproductive technology pregnancy. Gynecol Endocrinol 29:113–115CrossRefPubMedGoogle Scholar
  24. 24.
    Maggiore ULR, Ferrero S, Mangili G et al (2016) A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes. Hum Reprod Update 22:70–103CrossRefGoogle Scholar
  25. 25.
    Leone Roberti Maggiore U, Inversetti A, Schimberni M et al (2017) Obstetrical complications of endometriosis, particularly deep endometriosis. Fertil Steril 108:895–912CrossRefPubMedGoogle Scholar
  26. 26.
    Zullo F, Spagnolo E, Saccone G et al (2017) Endometriosis and obstetrics complications: a systematic review and meta-analysis. Fertil Steril 108:667–672CrossRefPubMedGoogle Scholar
  27. 27.
    Bulun SE (2009) Mechanisms of disease endometriosis. N Engl J Med 360:268–279CrossRefPubMedGoogle Scholar
  28. 28.
    Healy DL, Breheny S, Halliday J et al (2010) Prevalence and risk factors for obstetric haemorrhage in 6730 singleton births after assisted reproductive technology in Victoria Australia. Hum Reprod 25:265–274CrossRefPubMedGoogle Scholar
  29. 29.
    Romundstad LB, Romundstad PR, Sunde A et al (2006) Increased risk of placenta previa in pregnancies following IVF/ICSI; a comparison of ART and non-ART pregnancies in the same mother. Hum Reprod 21:2353–2358CrossRefPubMedGoogle Scholar
  30. 30.
    Shevell T, Malone FD, Vidaver J et al (2005) Assisted reproductive technology and pregnancy outcome. Obstet Gynecol 106:1039–1045CrossRefPubMedGoogle Scholar
  31. 31.
    Sumners J, Ecker JL, Practice CO et al (2016) Perinatal risks associated with assisted reproductive technology. Obstet Gynecol 128:E61–E68CrossRefGoogle Scholar
  32. 32.
    Hamdan M, Omar SZ, Dunselman G et al (2015) Influence of endometriosis on assisted reproductive technology outcomes a systematic review and meta-analysis. Obstet Gynecol 125:79–88CrossRefPubMedGoogle Scholar
  33. 33.
    Pérez-López FR, Villagrasa-Boli P, Muñoz-Olarte M et al (2018) Association between endometriosis and preterm birth in women with spontaneous conception or using assisted reproductive technology: a systematic review and meta-analysis of cohort studies. Reprod Sci 25:311–319CrossRefPubMedGoogle Scholar
  34. 34.
    Oyelese Y, Smulian JC (2006) Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 107:927–941CrossRefPubMedGoogle Scholar
  35. 35.
    Bulletti C, De Ziegler D, Polli V et al (2002) Characteristics of uterine contractility during menses in women with mild to moderate endometriosis. Fertil Steril 77:1156–1161CrossRefPubMedGoogle Scholar
  36. 36.
    Aghajanova L, Tatsumi K, Horcajadas JA et al (2011) Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis. Biol Reprod 84:801–815CrossRefPubMedGoogle Scholar
  37. 37.
    Benagiano G, Bastianelli C, Farris M et al (2014) Selective progesterone receptor modulators: an update. Expert Opin Pharmacother 15:1403–1415CrossRefPubMedGoogle Scholar
  38. 38.
    Bromer JG, Aldad TS, Taylor HS (2009) Defining the proliferative phase endometrial defect. Fertil Steril 91:698–704CrossRefPubMedGoogle Scholar
  39. 39.
    Burney RO, Talbi S, Hamilton AE et al (2007) Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 148:3814–3826CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Grandi G, Mueller M, Bersinger N et al (2016) Progestin suppressed inflammation and cell viability of tumor necrosis factor-alpha-stimulated endometriotic stromal cells. Am J Reprod Immunol 76:292–298CrossRefPubMedGoogle Scholar
  41. 41.
    Nirgianakis K, Bersinger NA, McKinnon B et al (2013) Regression of the inflammatory microenvironment of the peritoneal cavity in women with endometriosis by GnRHa treatment. Eur J Obstet Gynecol Reprod Biol 170:550–554CrossRefPubMedGoogle Scholar
  42. 42.
    Nirgianakis K, Grandi G, McKinnon B et al (2016) Dienogest mediates midkine suppression in endometriosis. Hum Reprod 31:1981–1986CrossRefPubMedGoogle Scholar
  43. 43.
    Miller DA, Chollet JA, Goodwin TM (1997) Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 177:210–214CrossRefPubMedGoogle Scholar
  44. 44.
    Higgins J, Thompson S, Deeks J et al (2002) Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 7:51–61CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Higgins JPT, Thompson SG, Deeks J (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Song F, Eastwood AJ, Gilbody S et al (2000) Publication and related biases. Health Technol Assess 4:1–115PubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Gynecology and ObstetricsUniversity Hospital of Bern and University of BernBernSwitzerland
  2. 2.Department of Gynecology and Obstetrics“Sapienza” University of RomeRomeItaly
  3. 3.Surgical and Medical Department of Translational Medicine“Sapienza” University of RomeRomeItaly

Personalised recommendations